Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 21467017.
- Also identified by DOI 10.1093/cid/cir087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antimicrobial and antimotility agents are not recommended for the treatment of Shiga toxin-producing Escherichia coli O157 infection. In our study, many persons with Shiga toxin-producing E. coli O157 infection took antimicrobial (62%) and antimotility agents (32%); 43 (29%) of 146 reported commencing antimicrobial treatment after laboratory confirmation. Efforts are needed to promote practice guidelines.
Medical subject headings
- Anti-Bacterial Agents
- Escherichia coli Infections
- Escherichia coli O157
- Hemolytic-Uremic Syndrome
- Parasympatholytics
- Shiga Toxins